| 000 | 01714 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516040532.0 | ||
| 264 | 0 | _c20120223 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1432-0584 | ||
| 024 | 7 |
_a10.1007/s00277-011-1255-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAvivi, Irit | |
| 245 | 0 | 0 |
_aLow incidence of long-term respiratory impairment in Hodgkin lymphoma survivors. _h[electronic resource] |
| 260 |
_bAnnals of hematology _cFeb 2012 |
||
| 300 |
_a215-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBleomycin _xadverse effects |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 |
_aDacarbazine _xadverse effects |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
| 650 | 0 | 4 |
_aDyspnea _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRespiratory Function Tests |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvivors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVinblastine _xadverse effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHardak, Emilia | |
| 700 | 1 | _aShaham, Beatrice | |
| 700 | 1 | _aIgla, Mordechai | |
| 700 | 1 | _aRowe, Jacob M | |
| 700 | 1 | _aDann, Eldad J | |
| 773 | 0 |
_tAnnals of hematology _gvol. 91 _gno. 2 _gp. 215-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00277-011-1255-7 _zAvailable from publisher's website |
| 999 |
_c20865560 _d20865560 |
||